ALKERMES PLC's ticker is ALKS and the CUSIP is G01767105. A total of 290 filers reported holding ALKERMES PLC in Q4 2015. The put-call ratio across all filers is 0.77 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $6,263,000 | +38.7% | 112,682 | +17.4% | 0.01% | +16.7% |
| Q3 2016 | $4,515,000 | +8.1% | 96,001 | -0.7% | 0.01% | +20.0% |
| Q2 2016 | $4,176,000 | +7.2% | 96,632 | -15.2% | 0.01% | 0.0% |
| Q1 2016 | $3,896,000 | -71.0% | 113,951 | -32.6% | 0.01% | -70.6% |
| Q4 2015 | $13,421,000 | +12.1% | 169,071 | -17.1% | 0.02% | +6.2% |
| Q3 2015 | $11,968,000 | -5.8% | 203,996 | +3.3% | 0.02% | 0.0% |
| Q2 2015 | $12,704,000 | +24.2% | 197,446 | +17.7% | 0.02% | +23.1% |
| Q1 2015 | $10,230,000 | +5.6% | 167,795 | +1.4% | 0.01% | 0.0% |
| Q4 2014 | $9,691,000 | +29.4% | 165,485 | -5.3% | 0.01% | +30.0% |
| Q3 2014 | $7,490,000 | -27.7% | 174,711 | -15.1% | 0.01% | -28.6% |
| Q2 2014 | $10,358,000 | +131.8% | 205,807 | +103.1% | 0.01% | +133.3% |
| Q1 2014 | $4,468,000 | +2.5% | 101,345 | -5.5% | 0.01% | 0.0% |
| Q4 2013 | $4,359,000 | +195.3% | 107,194 | +144.2% | 0.01% | +200.0% |
| Q3 2013 | $1,476,000 | +19.5% | 43,898 | +1.9% | 0.00% | 0.0% |
| Q2 2013 | $1,235,000 | – | 43,072 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Woodford Investment Management Ltd | 2,639,676 | $96,322,000 | 7.78% |
| Meditor Group Ltd | 892,400 | $32,564,000 | 6.11% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 233,000 | $8,502,000 | 3.14% |
| Tamarack Advisers, LP | 140,000 | $5,109,000 | 2.03% |
| Asymmetry Capital Management, L.P. | 27,673 | $1,010,000 | 1.69% |
| First Light Asset Management, LLC | 211,164 | $7,705,000 | 1.00% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 304,992 | $11,129,000 | 0.85% |
| Nicollet Investment Management, Inc. | 28,020 | $1,022,000 | 0.67% |
| PRIMECAP MANAGEMENT CO/CA/ | 23,263,530 | $848,886,000 | 0.62% |
| Rhenman & Partners Asset Management AB | 120,399 | $4,393,000 | 0.51% |